Ravandi F - Search Results

1

Proteomic profiling identifies distinct protein patterns in acute myelogenous leukemia CD34+CD38- stem-like cells.

Kornblau SM, Qutub A, Yao H, York H, Qiu YH, Graber D, Ravandi F, Cortes J, Andreeff M, Zhang N, Coombes KR. Kornblau SM, et al. Among authors: ravandi f. PLoS One. 2013 Oct 24;8(10):e78453. doi: 10.1371/journal.pone.0078453. eCollection 2013. PLoS One. 2013. PMID: 24223100 Free PMC article.

2

Chronic myelogenous leukaemia with p185(BCR/ABL) expression: characteristics and clinical significance.

Ravandi F, Cortes J, Albitar M, Arlinghaus R, Qiang Guo J, Talpaz M, Kantarjian HM. Ravandi F, et al. Br J Haematol. 1999 Dec;107(3):581-6. doi: 10.1046/j.1365-2141.1999.01736.x. Br J Haematol. 1999. PMID: 10583263 Free article.

3

Translocation t(17;18)(q10;q10): a new nonrandom chromosomal translocation of clonal evolution in chronic myeloid leukemia.

Ravandi F, Hayes K, Cortes J, Albitar M, Glassman A, Talpaz M, Kantarjian HM. Ravandi F, et al. Cancer. 2001 May 1;91(9):1704-8. Cancer. 2001. PMID: 11335894 No abstract available.

4

Expression of apoptosis proteins in chronic myelogenous leukemia: associations and significance.

Ravandi F, Kantarjian HM, Talpaz M, O'Brien S, Faderl S, Giles FJ, Thomas D, Cortes J, Andreeff M, Estrov Z, Rios MB, Albitar M. Ravandi F, et al. Cancer. 2001 Jun 1;91(11):1964-72. doi: 10.1002/1097-0142(20010601)91:11<1964::aid-cncr1221>3.0.co;2-b. Cancer. 2001. PMID: 11391574

5

CD56 expression predicts occurrence of CNS disease in acute lymphoblastic leukemia.

Ravandi F, Cortes J, Estrov Z, Thomas D, Giles FJ, Huh YO, Pierce S, O'Brien S, Faderl S, Kantarjian HM. Ravandi F, et al. Leuk Res. 2002 Jul;26(7):643-9. doi: 10.1016/s0145-2126(01)00188-6. Leuk Res. 2002. PMID: 12008081

6

New agents in acute myeloid leukemia and other myeloid disorders.

Ravandi F, Kantarjian H, Giles F, Cortes J. Ravandi F, et al. Cancer. 2004 Feb 1;100(3):441-54. doi: 10.1002/cncr.11935. Cancer. 2004. PMID: 14745859 Free article. Review.

7

Investigational agents in myeloid disorders.

Ravandi F, Cortes J. Ravandi F, et al. Adv Pharmacol. 2004;51:59-97. doi: 10.1016/S1054-3589(04)51003-7. Adv Pharmacol. 2004. PMID: 15464905 Review. No abstract available.

8

Adult acute megakaryocytic leukemia: an analysis of 37 patients treated at M.D. Anderson Cancer Center.

Oki Y, Kantarjian HM, Zhou X, Cortes J, Faderl S, Verstovsek S, O'Brien S, Koller C, Beran M, Bekele BN, Pierce S, Thomas D, Ravandi F, Wierda WG, Giles F, Ferrajoli A, Jabbour E, Keating MJ, Bueso-Ramos CE, Estey E, Garcia-Manero G. Oki Y, et al. Among authors: ravandi f. Blood. 2006 Feb 1;107(3):880-4. doi: 10.1182/blood-2005-06-2450. Epub 2005 Aug 25. Blood. 2006. PMID: 16123215 Free article.

9

Phase I study of cloretazine (VNP40101M), a novel sulfonylhydrazine alkylating agent, combined with cytarabine in patients with refractory leukemia.

Giles F, Verstovsek S, Thomas D, Gerson S, Cortes J, Faderl S, Ferrajoli A, Ravandi F, Kornblau S, Garcia-Manero G, Jabbour E, O'Brien S, Karsten V, Cahill A, Yee K, Albitar M, Sznol M, Kantarjian H. Giles F, et al. Among authors: ravandi f. Clin Cancer Res. 2005 Nov 1;11(21):7817-24. doi: 10.1158/1078-0432.CCR-05-1070. Clin Cancer Res. 2005. PMID: 16278404 Clinical Trial.

10

T-cell prolymphocytic leukemia: a single-institution experience.

Ravandi F, O'Brien S, Jones D, Lerner S, Faderl S, Ferrajoli A, Wierda W, Garcia-Manero G, Thomas D, Koller C, Verstovsek S, Giles F, Cortes J, Herling M, Kantarjian H, Keating M. Ravandi F, et al. Clin Lymphoma Myeloma. 2005 Nov;6(3):234-9. doi: 10.3816/CLM.2005.n.051. Clin Lymphoma Myeloma. 2005. PMID: 16354329

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

834 results

Search Page